Publication: Gut and oral microbiota profiling in patients (pts) with hormone receptor-positive (HR plus ) metastatic breast cancer (MBC) receiving pembrolizumab (P) plus eribulin (E): CALADRIO
dc.conference.date | MAY 03-05, 2022 | |
dc.conference.title | European-Society-for-Medical-Oncology (ESMO) Breast Cancer Congress | |
dc.contributor.author | Teng, N. | |
dc.contributor.author | Dalby, M. J. | |
dc.contributor.author | Kiu, R. | |
dc.contributor.author | Robinson, T. | |
dc.contributor.author | Cortes, M. Gion | |
dc.contributor.author | Bermejo De las Heras, B. | |
dc.contributor.author | Perez Garcia, J. M. | |
dc.contributor.author | Calvo-Martinez, L. | |
dc.contributor.author | Prat, A. | |
dc.contributor.author | Marquez Vazquez, R. | |
dc.contributor.author | Ruiz Borrego, M. | |
dc.contributor.author | de la Cruz, S. | |
dc.contributor.author | Llombart Cussac, A. | |
dc.contributor.author | Curigliano, G. | |
dc.contributor.author | Schmid, P. | |
dc.contributor.author | Mancino, M. | |
dc.contributor.author | Hall, L. | |
dc.contributor.author | Robinson, S. | |
dc.contributor.author | Cortes, J. | |
dc.contributor.author | Malfettone, A. | |
dc.contributor.authoraffiliation | [Teng, N.] Quadram Inst Biosci, Gut Microbes Hlth, Norwich, Norfolk, England | |
dc.contributor.authoraffiliation | [Dalby, M. J.] Quadram Inst Biosci, Gut Microbes Hlth, Norwich, Norfolk, England | |
dc.contributor.authoraffiliation | [Kiu, R.] Quadram Inst Biosci, Gut Microbes Hlth, Norwich, Norfolk, England | |
dc.contributor.authoraffiliation | [Hall, L.] Quadram Inst Biosci, Gut Microbes Hlth, Norwich, Norfolk, England | |
dc.contributor.authoraffiliation | [Robinson, S.] Quadram Inst Biosci, Gut Microbes Hlth, Norwich, Norfolk, England | |
dc.contributor.authoraffiliation | [Robinson, T.] NHS Fdn Trust, Med Oncol Dept, Bristol Haematol & Oncol Ctr, Bristol, Avon, England | |
dc.contributor.authoraffiliation | [Cortes, M. Gion] Hosp Univ Ramon y Cajal, Dept Med Oncol, Madrid, Spain | |
dc.contributor.authoraffiliation | [Bermejo De las Heras, B.] Hosp Clin Univ Valencia, Med Oncol, Valencia, Spain | |
dc.contributor.authoraffiliation | [Perez Garcia, J. M.] Ctr Med Teknon, Dept Med Oncol, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Calvo-Martinez, L.] CHUAC Complexo Hosp Univ A Coruna, La Coruna, Spain | |
dc.contributor.authoraffiliation | [Prat, A.] Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Marquez Vazquez, R.] MD Anderson Canc Ctr Madrid, Madrid, Spain | |
dc.contributor.authoraffiliation | [Ruiz Borrego, M.] Hosp Univ Virgen del Rocio, Seville, Spain | |
dc.contributor.authoraffiliation | [de la Cruz, S.] Royal Navarre Hosp, Med Oncol, Complejo Hosp Navarra, Pamplona, Spain | |
dc.contributor.authoraffiliation | [Llombart Cussac, A.] Hosp Arnau Vilanova, Dept Med Oncol, Valencia, Spain | |
dc.contributor.authoraffiliation | [Curigliano, G.] IEO Ist Europeo Oncol, Early Drug Dev Innovat Therapies Div, Milan, Italy | |
dc.contributor.authoraffiliation | [Schmid, P.] Queen Mary Univ London, Barts Canc Inst, Ctr Expt Canc Med, London, England | |
dc.contributor.authoraffiliation | [Mancino, M.] MedSIR Med Scientia Innovat Res SL, Sci, Valencia, Spain | |
dc.contributor.authoraffiliation | [Cortes, J.] VHIO Valle de Hebron Inst Oncol, Dept Oncol, Barcelona, Spain | |
dc.contributor.authoraffiliation | [Malfettone, A.] MedSIR Med Scientia Innovat Res, Dept Sci, Barcelona, Spain | |
dc.date.accessioned | 2023-05-03T14:39:45Z | |
dc.date.available | 2023-05-03T14:39:45Z | |
dc.date.issued | 2022-05-05 | |
dc.identifier.doi | 10.1016/j.annonc.2022.03.029 | |
dc.identifier.essn | 1569-8041 | |
dc.identifier.issn | 0923-7534 | |
dc.identifier.unpaywallURL | http://www.annalsofoncology.org/article/S0923753422004082/pdf | |
dc.identifier.uri | http://hdl.handle.net/10668/21897 | |
dc.identifier.wosID | 792494100017 | |
dc.issue.number | 3 | |
dc.journal.title | Annals of oncology | |
dc.journal.titleabbreviation | Ann. oncol. | |
dc.language.iso | en | |
dc.organization | Hospital Universitario Virgen del Rocío | |
dc.page.number | S129-S130 | |
dc.publisher | Elsevier | |
dc.rights.accessRights | open access | |
dc.title | Gut and oral microbiota profiling in patients (pts) with hormone receptor-positive (HR plus ) metastatic breast cancer (MBC) receiving pembrolizumab (P) plus eribulin (E): CALADRIO | |
dc.type | conference output | |
dc.type.hasVersion | VoR | |
dc.volume.number | 33 | |
dc.wostype | Meeting Abstract | |
dspace.entity.type | Publication |